These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 25322648)
1. [Interaction of renin-angiotensin system inhibitors with dopamine in rat kidney]. Kuz'min OB; Landar' LN; Buchneva NV Eksp Klin Farmakol; 2014; 77(7):16-9. PubMed ID: 25322648 [TBL] [Abstract][Full Text] [Related]
2. [INTERACTION OF BETA-BLOCKER PROPRANOLOL WITH RENIN-ANGIOTENSIN SYSTEM INHIBITORS IN RAT KIDNEY]. Kuzmin OB; Buchneva NV; Landar LN Eksp Klin Farmakol; 2016; 79(3):27-30. PubMed ID: 27455575 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of the role of neurohumoral systems in action of dopaminomimetic dopamine on ion-regulating renal function]. Landar' LN; Kuz'min OB Eksp Klin Farmakol; 2013; 76(6):18-21. PubMed ID: 24003484 [TBL] [Abstract][Full Text] [Related]
4. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease. Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343 [TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat. Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats. Abdulla MH; Sattar MA; Abdullah NA; Hazim AI; Anand Swarup KR; Rathore HA; Khan MA; Johns EJ Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332 [TBL] [Abstract][Full Text] [Related]
7. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin. Zavala L; Barbella Y; Israel A J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973 [TBL] [Abstract][Full Text] [Related]
8. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696 [TBL] [Abstract][Full Text] [Related]
9. [The future of renin inhibition]. Uresin AY; Baran E Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475 [TBL] [Abstract][Full Text] [Related]
10. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats. Chen CJ; Apparsundaram S; Lokhandwala MF J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595 [TBL] [Abstract][Full Text] [Related]
11. Urinary cytokine profiles according to the site of blockade of the renin-angiotensin system in nephrectomized rats. Baracho NCDV; Silveira KDD; Rocha NP; Cordeiro TM; Feracin V; Pereira RM; Reis MAAD; Teixeira MM; Silva ACSE J Bras Nefrol; 2017; 39(2):108-118. PubMed ID: 29069238 [TBL] [Abstract][Full Text] [Related]
12. [Renin inhibition and the kidney]. Ecder T Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474 [TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients. López V; Martin M; Cobelo C; Aranda P; Cabello M; Sola E; Gutierrez C; Burgos D; Martínez D; Hernandez D Transplant Proc; 2010 Oct; 42(8):2883-5. PubMed ID: 20970559 [TBL] [Abstract][Full Text] [Related]
15. Effects of furosemide, captopril and indometacin on the renin-angiotensin system and the renal prostaglandins in anesthetized neonatal piglets. Joppich R; Weyer P; Eife R Arzneimittelforschung; 1995 Jul; 45(7):822-5. PubMed ID: 8573231 [TBL] [Abstract][Full Text] [Related]
16. Low sodium intake induces an increase in renal monoamine oxidase activity in the rat. Involvement of an angiotensin II dependent mechanism. De Luca Sarobe V; Nowicki S; Carranza A; Levin G; Barontini M; Arrizurieta E; Ibarra FR Acta Physiol Scand; 2005 Oct; 185(2):161-7. PubMed ID: 16168010 [TBL] [Abstract][Full Text] [Related]
17. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?]. Horký K Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167 [TBL] [Abstract][Full Text] [Related]
18. Mast cell population in the development of diabetic nephropathy: Effects of renin angiotensin system inhibition. de Morais RB; do Couto Muniz VP; Nunes Costa E; Filho SRF; Nakamura Hiraki KR; Bispo-da-Silva LB; Coelho Balbi AP Biomed Pharmacother; 2018 Nov; 107():1115-1118. PubMed ID: 30257323 [TBL] [Abstract][Full Text] [Related]
19. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects. Burnier M; Brunner HR Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896 [TBL] [Abstract][Full Text] [Related]
20. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats. Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]